Pay in 4 interest-free payments of $7.21 Learn more
Ships within 48 hours · Estimated delivery Sep 23 - Sep 28
Learn more about the similarities and differences of tirzepatide vs
Wall Street analysts expect between $33 billion and $100 billion in annual revenue from anti-obesity medications in the next six years, according to J.P
As a researcher who has dedicated their career to this and worked hard to get them FDA approved, its really hard to watch when the people who need these treatments the most are not able to get them.
Compounded Tirzepatide Compounded Semaglutide Same active ingredient as Ozempic & Wegovy GLP-1 receptor agonist (single target) Average weight loss: ~15% of body weight Once-weekly subcutaneous injection Gradual dose titration over 48 weeks Well-studied safety profile Good starting option for most patients Compounded Tirzepatide Same active ingredient as Mounjaro & Zepbound Dual GLP-1 + GIP receptor agonist Average weight loss: up to 21% of body weight Once-weekly subcutaneous injection Gradual dose titration over 48 weeks Additional blood sugar regulation via GIP pathway May be more effective for patients with insulin resistance Not sure which is right for you
Gluten Free, GMO Free, Soy Free, Dairy Free, Vegetarian, Vegan
